TickerFactsScreenerDevelopers

Arcadia Biosciences, Inc. (RKDA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2013: $2.83M2014: $16.57M2015: $23.97M2016: $2.01M2017: $9.12M2018: $12.00M2019: $8.42M2020: $14.04M2021: $28.68M2022: $20.64M2023: $6.52M2024: $4.24M2025: $259.0K$259.0K
2013Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$259.0K-93.9%
2024$4.24M-34.9%
2023$6.52M-68.4%
2022$20.64M-28.0%
2021$28.68M+104.3%
2020$14.04M+66.8%
2019$8.42M-29.8%
2018$12.00M+31.5%
2017$9.12M+353.3%
2016$2.01M-91.6%
2015$23.97M+44.7%
2014$16.57M+484.5%
2013$2.83M—